Xeris Biopharma

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell XERS and other ETFs, options, and stocks.

About XERS

Xeris Biopharma Holdings, Inc. is a biopharmaceutical company, which engages in developing and commercializing products across a range of therapies. The company has three commercial products: Gvoke, Keveyis, and Recorlev.

CEO

John Patrick Shannon

CEOJohn Patrick Shannon

Employees

394

Employees394

Headquarters

Chicago, Illinois

HeadquartersChicago, Illinois

Founded

2005

Founded2005

Employees

394

Employees394

XERS Key Statistics

Market cap

762.34M

Market cap762.34M

Price-Earnings ratio

-15.75

Price-Earnings ratio-15.75

Dividend yield

—

Dividend yield—

Average volume

2.14M

Average volume2.14M

High today

$4.84

High today$4.84

Low today

$4.70

Low today$4.70

Open price

$4.73

Open price$4.73

Volume

1.08M

Volume1.08M

52 Week high

$6.07

52 Week high$6.07

52 Week low

$2.05

52 Week low$2.05

People also own

Based on the portfolios of people who own XERS. This list is generated using Robinhood data, and it’s not a recommendation.